A new response-adaptive design for continuous treatment responses for phase III clinical trials

A new response-adaptive design, applicable for general class of continuous response distributions, is proposed. The allocation design is studied both theoretically and numerically and compared with some existing procedures. The applicability of the proposed procedure is also illustrated using real life data sets.